LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 513 | 10064 | 10401 | 0.9676 | 0.9659 |
MCF 10A | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 513 | 9517 | 10401 | 0.9150 | 0.9106 |
MCF 10A | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 6595 | 10401 | 0.6341 | 0.6151 |
MCF 10A | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 4328 | 10401 | 0.4162 | 0.3859 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 337 | 10401 | 0.0324 | -0.0178 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 305 | 10401 | 0.0293 | -0.0211 |
MCF 10A | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 1073 | 10401 | 0.1032 | 0.0566 |
MCF 10A | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 513 | 9146 | 10401 | 0.8793 | 0.8731 |
MCF 10A | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 667 | 10401 | 0.0641 | 0.0155 |
MCF 10A | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 1147 | 10401 | 0.1103 | 0.0641 |
MCF 10A | R406 | 3.33 | uM | LJP6 | 72 | hr | 513 | 5300 | 10401 | 0.5096 | 0.4842 |
MCF 10A | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 513 | 1104 | 10401 | 0.1062 | 0.0598 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 786 | 10401 | 0.0756 | 0.0276 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 513 | 389 | 10401 | 0.0374 | -0.0125 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 513 | 393 | 10401 | 0.0378 | -0.0122 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 513 | 348 | 10401 | 0.0335 | -0.0167 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 513 | 459 | 10401 | 0.0441 | -0.0055 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 513 | 2209 | 10401 | 0.2124 | 0.1715 |
MCF 10A | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 513 | 431 | 10401 | 0.0414 | -0.0083 |
MCF 10A | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 513 | 7222 | 10401 | 0.6944 | 0.6785 |
MCF 10A | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 513 | 701 | 10401 | 0.0674 | 0.0190 |
MCF 10A | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1445 | 10401 | 0.1389 | 0.0942 |
MCF 10A | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 513 | 2412 | 10401 | 0.2320 | 0.1921 |
MCF 10A | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 11182 | 10401 | 1.0751 | 1.0790 |
MCF 10A | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 513 | 592 | 10401 | 0.0569 | 0.0080 |